{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T07:25:48Z","timestamp":1774596348389,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,12,14]],"date-time":"2019-12-14T00:00:00Z","timestamp":1576281600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,14]],"date-time":"2019-12-14T00:00:00Z","timestamp":1576281600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CEN Case Rep"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1007\/s13730-019-00438-9","type":"journal-article","created":{"date-parts":[[2019,12,14]],"date-time":"2019-12-14T14:03:41Z","timestamp":1576332221000},"page":"109-113","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Unusual manifestation of monoclonal gammopathy of undetermined significance: a false serum creatinine elevation"],"prefix":"10.1007","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0278-6900","authenticated-orcid":false,"given":"Yoshinosuke","family":"Shimamura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuto","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yayoi","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Nagai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiya","family":"Shinohara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Takizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,12,14]]},"reference":[{"key":"438_CR1","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/0002-9343(78)90522-3","volume":"64","author":"RA Kyle","year":"1987","unstructured":"Kyle RA. Monoclonal gammopathy of undetermined significance: natural history in 241 cases. Am J Med. 1987;64:814\u201326.","journal-title":"Am J Med"},{"key":"438_CR2","doi-asserted-by":"publisher","first-page":"859","DOI":"10.4065\/79.7.859","volume":"79","author":"RA Kyle","year":"2004","unstructured":"Kyle RA, Therneau TM, Rajkumar SV, Larson DR, Plevak MF, Melton LJ III. Long-term follow-up of 241 patients with monoclonal gammopathy of undetermined significance: the original Mayo Clinic series 25 years later. Mayo Clin Proc. 2004;79:859\u201366.","journal-title":"Mayo Clin Proc"},{"key":"438_CR3","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1056\/NEJMoa1709974","volume":"378","author":"RA Kyle","year":"2018","unstructured":"Kyle RA, Larson DR, Therneau TM, Despenzieri A, Kumar S, Cerhan JR. Long-term follow-up of monoclonal gammopathy of undetermined significance. N Engl J Med. 2018;378:241\u20139.","journal-title":"N Engl J Med"},{"key":"438_CR4","first-page":"1273","volume-title":"Goldman-Cecil Medicine","author":"SV Rajkumar","year":"2016","unstructured":"Rajkumar SV. Plasma cell disorders. In: Goldman L, Schafer AI, editors. Goldman-Cecil Medicine. 25th ed. Philadelphia: Elsevier Saunders; 2016. p. 1273\u20131284.","edition":"25"},{"key":"438_CR5","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1179\/acb.2004.039","volume":"59","author":"M Berth","year":"2004","unstructured":"Berth M, Delanghe J. Protein precipitation as a possible important pitfall in the clinical chemistry analysis of blood samples containing monoclonal immunoglobulins: 2 case reports and a review of the literature. Acta Clin Belg. 2004;59:263\u201373.","journal-title":"Acta Clin Belg"},{"key":"438_CR6","unstructured":"Pure-auto S CRE-N\u00ae. SEKISUI MEDICAL Co., ltd. 2017. https:\/\/www.info.pmda.go.jp\/tgo\/pack\/20800AMZ10178000_A_01_07\/ Accessed 05 Nov 2019. (in Japanese)"},{"key":"438_CR7","unstructured":"Pure-auto S CRE-L\u00ae. SEKISUI MEDICAL Co., ltd. 2017. https:\/\/www.info.pmda.go.jp\/tgo\/pack\/21300AMZ00422000_A_01_05\/ Accessed 05 Nov 2019. (in Japanese)"},{"key":"438_CR8","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1373\/clinchem.2004.037499","volume":"50","author":"A Smogorzewska","year":"2004","unstructured":"Smogorzewska A, Flood JG, Long WH, Dighe AS. Paraprotein interference in automated chemistry analyzers. Clin Chem. 2004;50:1691\u20133.","journal-title":"Clin Chem"},{"key":"438_CR9","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.cccn.2005.02.008","volume":"358","author":"LY Tsai","year":"2005","unstructured":"Tsai LY, Tsai SM, Lee SC, Liu SF. Falsely low LDL-cholesterol concentrations and artifactual undetectable HDL-cholesterol measured by direct methods in a patient with monoclonal paraprotein. Clin Chem Acta. 2005;358:192\u20135.","journal-title":"Clin Chem Acta"},{"key":"438_CR10","doi-asserted-by":"crossref","first-page":"55","DOI":"10.5858\/2003-127-55-AHDTP","volume":"127","author":"L Pantanowitz","year":"2003","unstructured":"Pantanowitz L, Horowitz GL, Upalakalin JN, Beckwith BA. Artifactual hyperbilirubinemia due to paraprotein interference. Arch Pathol Lab. 2003;127:55\u20139.","journal-title":"Arch Pathol Lab"},{"key":"438_CR11","doi-asserted-by":"publisher","first-page":"2772","DOI":"10.1056\/NEJMcpc069031","volume":"355","author":"MR Murali","year":"2006","unstructured":"Murali MR, Kratz A, Finberg KE. Case records of the Massachusetts General Hospital. Case 40\u20132006. A 64-year-old man with anemia and a low level of HDL cholesterol. N Engl J Med. 2006;355:2772\u20139.","journal-title":"N Engl J Med"},{"key":"438_CR12","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1182\/blood-2006-05-023762","volume":"109","author":"MA Alyanakian","year":"2007","unstructured":"Alyanakian MA, Taes Y, Bensa\u00efd M, Segovia B, Aucouturier P, Rain JD, et al. Monoclonal immunoglobulin with antitransferrin activity: a rare cause of hypersideremia with increased transferrin saturation. Blood. 2007;109:359\u201361.","journal-title":"Blood"},{"key":"438_CR13","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/ki.2011.427","volume":"81","author":"P Krish","year":"2012","unstructured":"Krish P, Jhaveri KD. Hyperbicarbonatemia in a patient with Waldenstrom's macroglobulinemia Pseudohyperbicarbonatemia due to paraproteinemia. Kidney Int. 2012;81:603\u20135.","journal-title":"Kidney Int"},{"key":"438_CR14","doi-asserted-by":"crossref","first-page":"217","DOI":"10.5858\/2008-132-217-PAACCO","volume":"132","author":"Y Yang","year":"2008","unstructured":"Yang Y, Howanitz PJ, Howanitz JH, Gorfajn H, Wong K. Paraproteins are a common cause of interferences with automated chemistry methods. Arch Pathol Lab Med. 2008;132:217\u201323.","journal-title":"Arch Pathol Lab Med"},{"key":"438_CR15","first-page":"547","volume":"66","author":"M Miyoshi","year":"2017","unstructured":"Miyoshi M, Nishioka M, Hata M, Nakao T, Doi T. Comparative study of measurement error for creatinine concentration in serum six reagents. Jpn J Med Tech. 2017;66:547\u201353 (in Japanese).","journal-title":"Jpn J Med Tech"},{"key":"438_CR16","first-page":"43","volume":"46","author":"M Yamaki","year":"2004","unstructured":"Yamaki M. A case of pseudohypercreatinemia in a patient suffering from macroglobulinemia. Jpn J Nephrol. 2004;46:43\u20138 (in Japanese).","journal-title":"Jpn J Nephrol"},{"key":"438_CR17","doi-asserted-by":"publisher","first-page":"3337","DOI":"10.1093\/ndt\/gfl353","volume":"21","author":"L Storsley","year":"2006","unstructured":"Storsley L, Fine A, Krahn J. IgM monoclonal protein presenting as pseudohypercreatinaemia. Nephrol Dial Transplant. 2006;21:3337\u20138.","journal-title":"Nephrol Dial Transplant"},{"key":"438_CR18","first-page":"1340","volume":"55","author":"M Ikeda","year":"2013","unstructured":"Ikeda M, Tsukamoto T, Miyake T, Kakita H, Komiya T, Yonemoto S, et al. A case of pseudohypercreatinemia associated with monoclonal IgM gammopathy. Jpn J Nephrol. 2013;55:1340\u20134 (in Japanese).","journal-title":"Jpn J Nephrol"},{"key":"438_CR19","doi-asserted-by":"publisher","first-page":"xiv","DOI":"10.1053\/j.ajkd.2017.09.027","volume":"71","author":"MJ Kadatz","year":"2018","unstructured":"Kadatz MJ, Lee ES, Duncan J, Levin A, Johnson O. A peculiar case of Paraproteinemia and elevated creatinine. Am J Kidney Dis. 2018;71:xiv\u2013xv.","journal-title":"Am J Kidney Dis"},{"key":"438_CR20","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1159\/000045741","volume":"86","author":"KM Hummel","year":"2000","unstructured":"Hummel KM, von Ahsen N, K\u00fchn RB, Grunewald RW, Oellerich M, M\u00fcller GA. Pseudohypercreatiniemia due to positive interference in enzymatic creatinine measurements caused by monoclonal IgM in patients with Waldenstr\u00f6m\u2019s macroglobulinemia. Nephron. 2000;86:188\u20139.","journal-title":"Nephron"},{"key":"438_CR21","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/ki.2009.465","volume":"77","author":"G Rudofsky","year":"2010","unstructured":"Rudofsky G, Villalobos M, Waldherr R, Schair M, Zorn M, Maimer A, et al. Renal failure in a male with Waldenstr\u00f6m\u2019s macroglobulinemia. Kidney Int. 2010;77:371\u20132.","journal-title":"Kidney Int"},{"key":"438_CR22","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/ki.2010.246","volume":"78","author":"J Kwok","year":"2010","unstructured":"Kwok J, Chow KM, Lit L, Chan M. Paraproteinemia-associated pseudohypercreatinemia across different analytical methodologies. Kidney Int. 2010;78:621.","journal-title":"Kidney Int"},{"key":"438_CR23","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1373\/clinchem.2004.045740","volume":"51","author":"CR Sheppard","year":"2005","unstructured":"Sheppard CR, Allen RC, Austin GE, Young AN, Ribeiro MA, Fantz CR. Paraprotein interference in automated chemistry analyzers. Clin Chem. 2005;51:1077\u20138.","journal-title":"Clin Chem"},{"key":"438_CR24","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1093\/clinchem\/33.6.1075a","volume":"33","author":"RG Reed","year":"1987","unstructured":"Reed RG. Interference by an IgM paraprotein in the bromcresol green method for determination of serum albumin. Clin Chem. 1987;33:1075\u20136.","journal-title":"Clin Chem"},{"key":"438_CR25","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1053\/ajkd.2000.8237","volume":"36","author":"E Coll","year":"2000","unstructured":"Coll E, Botey A, Alvarez L, Poch E, Quinto L, Saurina A, et al. Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment. Am J Kidney Dis. 2000;36:29\u201334.","journal-title":"Am J Kidney Dis"},{"key":"438_CR26","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1373\/clinchem.2011.167494","volume":"58","author":"MA Ferguson","year":"2012","unstructured":"Ferguson MA, Waiker SS. Established and emerging markers of kidney function. Clin Chem. 2012;58:680\u20139.","journal-title":"Clin Chem"},{"key":"438_CR27","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1093\/clinchem\/44.7.1535","volume":"44","author":"BG Keevil","year":"1998","unstructured":"Keevil BG, Kilpatrick ES, Nichols SP, Maylor PW. Biological variation of cystatin C: implications for the assessment of glomerular filtration rate. Clin Chem. 1998;44:1535\u20139.","journal-title":"Clin Chem"},{"key":"438_CR28","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1093\/clinchem\/40.10.1921","volume":"40","author":"J Kyhse-Andersen","year":"1994","unstructured":"Kyhse-Andersen J, Schmidt C, Nordin G, Andersson B, Nilsson-Ehle P, Lindst\u00f6m V, et al. Serum cystatin C, determined by a rapid, automated particle-enhanced turbidimetric method, is a better marker than serum creatinine for glomerular filtration rate. Clin Chem. 1994;40:1921\u20136.","journal-title":"Clin Chem"},{"key":"438_CR29","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1515\/CCLM.1998.151","volume":"36","author":"M Mussap","year":"1998","unstructured":"Mussap M, Ruzzante N, Varagnolo M, Plebani M. Quantitative automated particle-enhanced immunonephelometric assay for the routine measurement of human cystatin C. Clin Chem Lab Med. 1998;36:859\u201365.","journal-title":"Clin Chem Lab Med"},{"key":"438_CR30","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.clinbiochem.2003.08.001","volume":"37","author":"M Tanaka","year":"2004","unstructured":"Tanaka M, Matsuo K, Enomoto M, Mizuno K. A sol particle homogenous immunoassay for measuring serum cystatin C. Clin Biochem. 2004;37:27\u201335.","journal-title":"Clin Biochem"},{"key":"438_CR31","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3960\/jslrt.17025","volume":"57","author":"H Tanaka","year":"2017","unstructured":"Tanaka H, Sakuma Y, Ikeda H, Shimizu R, Sugita Y, Iwai R. Characteristics and prognosis of patients with immunoglobulin M monoclonal gammopathy. J Clin Exp Hematop. 2017;57:47\u201353.","journal-title":"J Clin Exp Hematop"}],"container-title":["CEN Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-019-00438-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13730-019-00438-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-019-00438-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,12]],"date-time":"2021-02-12T06:41:19Z","timestamp":1613112079000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13730-019-00438-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,14]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["438"],"URL":"https:\/\/doi.org\/10.1007\/s13730-019-00438-9","relation":{},"ISSN":["2192-4449"],"issn-type":[{"value":"2192-4449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,14]]},"assertion":[{"value":"24 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have declared that no conflict of interest exists.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee at which the studies were conducted (IRB approval number: 2017-125) and followed the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}